Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2007-01-01

Clinical Trial Update: To Evaluate the Long-Term Safety and Efficacy of Pregabalin in Patients With Partial Seizures. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing the long-term safety and efficacy of pregabalin in patients with partial seizures has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lyrica (Pregabalin)

Snippet

Sponsor: Pfizer | Conditions: Seizure Disorder, Partial | Phase 3 | Status: COMPLETED